Related references
Note: Only part of the references are listed.The prostate metastasis suppressor gene NDRG1 differentially regulates cell motility and invasion
Anup Sharma et al.
MOLECULAR ONCOLOGY (2017)
The metastatic suppressor NDRG1 inhibits EMT, migration and invasion through interaction and promotion of caveolin-1 ubiquitylation in human colorectal cancer cells
L. Mi et al.
ONCOGENE (2017)
Discovery of new substrates of the elongation factor-2 kinase suggests a broader role in the cellular nutrient response
Michael B. Lazarus et al.
CELLULAR SIGNALLING (2017)
Eukaryotic elongation factor 2 kinase regulates thesynthesis of microtubule-related proteins in neurons
Justin W. Kenney et al.
JOURNAL OF NEUROCHEMISTRY (2016)
MicroRNA-877 acts as a tumor suppressor by directly targeting eEF2K in renal cell carcinoma
Qianqian Shi et al.
ONCOLOGY LETTERS (2016)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Elongation factor 2 kinase promotes cell survival by inhibiting protein synthesis without inducing autophagy
Claire E. J. Moore et al.
CELLULAR SIGNALLING (2016)
Pharmacological eEF2K activation promotes cell death and inhibits cancer progression
Aude De Gassart et al.
EMBO REPORTS (2016)
eEF-2 kinase is a critical regulator of Warburg effect through controlling PP2A-A synthesis
Y. Cheng et al.
ONCOGENE (2016)
FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells
Zuhal Hamurcu et al.
ONCOTARGET (2016)
Targeting the Metastasis Suppressor, N-Myc Downstream Regulated Gene-1, with Novel Di-2-Pyridylketone Thiosemicarbazones: Suppression of Tumor Cell Migration and Cell-Collagen Adhesion by Inhibiting Focal Adhesion Kinase/Paxillin Signaling
Xiongzhi Wangpu et al.
MOLECULAR PHARMACOLOGY (2016)
Regulated stability of eukaryotic elongation factor 2 kinase requires intrinsic but not ongoing activity
Xuemin Wang et al.
BIOCHEMICAL JOURNAL (2015)
The MAP kinase-interacting kinases regulate cell migration, vimentin expression and eIF4E/CYFIP1 binding
James E. Beggs et al.
BIOCHEMICAL JOURNAL (2015)
Differential Requirements for eIF4E Dose in Normal Development and Cancer
Morgan L. Truitt et al.
CELL (2015)
Elongation Factor 2 Kinase Is Regulated by Proline Hydroxylation and Protects Cells during Hypoxia
Claire E. J. Moore et al.
MOLECULAR AND CELLULAR BIOLOGY (2015)
Molecular Mechanism for the Control of Eukaryotic Elongation Factor 2 Kinase by pH: Role in Cancer Cell Survival
Jianling Xie et al.
MOLECULAR AND CELLULAR BIOLOGY (2015)
Eukaryotic elongation factor 2 kinase controls proliferation and migration of vascular smooth muscle cells
T. Usui et al.
ACTA PHYSIOLOGICA (2015)
mTORC1-mediated translational elongation limits intestinal tumour initiation and growth
William J. Faller et al.
NATURE (2015)
Phosphorylation of eIF4E promotes EMT and metastasis via translational control of SNAIL and MMP-3
N. Robichaud et al.
ONCOGENE (2015)
Translation elongation can control translation initiation on eukaryotic mRNAs
Dominique Chu et al.
EMBO JOURNAL (2014)
Combined deletion of Pten and p53 in mammary epithelium accelerates triple-negative breast cancer with dependency on eEF2K
Jeff C. Liu et al.
EMBO MOLECULAR MEDICINE (2014)
Elongation factor-2 kinase regulates TG2/β1 integrin/Src/uPAR pathway and epithelial-mesenchymal transition mediating pancreatic cancer cells invasion
Ahmed A. Ashour et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2014)
Eukaryotic Elongation Factor 2 Kinase Activity Is Controlled by Multiple Inputs from Oncogenic Signaling
Xuemin Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
The integrin adhesome: from genes and proteins to human disease
Sabina E. Winograd-Katz et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Molecular mechanisms of epithelial-mesenchymal transition
Samy Lamouille et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
The eEF2 Kinase Confers Resistance to Nutrient Deprivation by Blocking Translation Elongation
Gabriel Leprivier et al.
CELL (2013)
Stable isotope-labelling analysis of the impact of inhibition of the mammalian target of rapamycin on protein synthesis
Yilin Huo et al.
BIOCHEMICAL JOURNAL (2012)
Identification of autophosphorylation sites in eukaryotic elongation factor-2 kinase
Sebastien Pyr Dit Ruys et al.
BIOCHEMICAL JOURNAL (2012)
Investigating the Kinetic Mechanism of Inhibition of Elongation Factor 2 Kinase by NH125: Evidence of a Common in Vitro Artifact
Ashwini K. Devkota et al.
BIOCHEMISTRY (2012)
The translational landscape of mTOR signalling steers cancer initiation and metastasis
Andrew C. Hsieh et al.
NATURE (2012)
1-Benzyl-3-cetyl-2-methylimidazolium iodide (NH125) Induces Phosphorylation of Eukaryotic Elongation Factor-2 (eEF2) A CAUTIONARY NOTE ON THE ANTICANCER MECHANISM OF AN eEF2 KINASE INHIBITOR
Zehan Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with In vitro and In vivo Antitumor Activity
Christine M. Chresta et al.
CANCER RESEARCH (2010)
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
DD Sarbassov et al.
SCIENCE (2005)
Stimulation of the AMP-activated protein kinase leads to activation of eukaryotic elongation factor 2 kinase and to its phosphorylation at a novel site, Serine 398
GJ Browne et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
ONCOMINE: A cancer microarray database and integrated data-mining platform
DR Rhodes et al.
NEOPLASIA (2004)
Share Paper
